Michael Wrangstadh

Statistics

Publications

Citations

1.9K

H-Index

Active since

1986

Affiliations

AstraZeneca (Sweden)(Current)

Skaraborg Hospital

Otto-von-Guericke-Universität Magdeburg

Semmelweis University

Tallaght University Hospital

Michael Wrangstadh is an author at AstraZeneca (Sweden) specializing in clinical pharmacology, helicobacter pylori eradication, and helicobacter pylori infection.

Publications per year

1986–2010

Publications

Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study

Tore Lind, Sander Veldhuyzen van Zanten, Peter Unge et al. · Helicobacter · 1996 · 575 citations

Medicine, Pharmacology, Pharmacotherapy +16

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

Tore Lind, Françis Mégraud, Peter Unge et al. · Gastroenterology · 1999 · 433 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Antimicrobial Susceptibility Testing of <i>Helicobacter pylori</i> in a Large Multicenter Trial: the MACH 2 Study

Françis Mégraud, Norbert Lehn, Tore Lind et al. · Antimicrobial Agents and Chemotherapy · 1999 · 266 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

The production and release of an extracellular polysaccharide during starvation of a marine Pseudomonas sp. and the effect thereof on adhesion

Michael Wrangstadh, Patricia L. Conway, Staffan Kjelleberg · Archives of Microbiology · 1986 · 136 citations

Life Sciences, Marine Biology, Microbiology +16

Relevance of the exopolysaccharide of marine Pseudomonas sp. strain S9 for the attachment of Ciona intestinalis larvae

Ulrich Szewzyk, Carola Holmström, Michael Wrangstadh et al. · Marine Ecology Progress Series · 1991 · 111 citations · Full text

Life Sciences, Marine Sciences, Microbiology +13

1–5 of 14